Healthcare - Sector
Acasti Pharma's activity chart (see below) currently has 14 price targets and 16 ratings on display.
Analysts' price targets on this stock were met 10% of the time, taking 3.8 days on average.
Most recent stock forecast was given by OREN LIVNAT from on 26-Sep-2024. First documented stock forecast 26-Jun-2019.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 12-Jul-2023
$12
$12
2 years 1 months 27 days ago
(26-Sep-2024)
0/2 (0%)
$8.93 (290.88%)
Buy Since 18-Jul-2019
$29.41
$30
4 years 5 months ago
(22-Jun-2022)
0/5 (0%)
$24 (443.62%)
Buy Since 09-Jul-2019
$12
$144
6 years 2 months 20 days ago
(02-Sep-2020)
1/2 (50%)
$1.58 (15.16%)
19
Buy Since 31-Aug-2020
$96
6 years 2 months 22 days ago
(31-Aug-2020)
0/2 (0%)
$66.72 (227.87%)
Buy Since 26-Jun-2019
$150
$288
6 years 9 months 4 days ago
(18-Feb-2020)
0/2 (0%)
$122.69 (449.25%)
What is ACST (Acasti Pharma) average time for price targets to be met?
Which analyst most recently updated their price target on ACST (Acasti Pharma)?
Which analyst has the lowest performance score on ACST (Acasti Pharma) with a proven track record?
Which analyst has the most public recommendations on ACST (Acasti Pharma)?
Which analyst is the currently most bullish on ACST (Acasti Pharma)?
Which analyst is the currently most reserved on ACST (Acasti Pharma)?